Severe coronavirus disease 2019 (COVID-19) is associated with increased risk of venous
thromboembolism events (VTE). This study performed a systematic review in …

To determine, in patients with coronavirus disease 2019 (COVID-19) infection, the
associations of pulmonary embolism (PE) with mortality and risk factors for PE as well as the …

Background The prevalence of venous thromboembolic event (VTE) and arterial
thromboembolic event (ATE) thromboembolic events in patients with COVID-19 remains …

Background Pulmonary embolisms are frequently and prognostically in individuals infected
by coronavirus disease 2019 (COVID-19); the incidence of pulmonary embolisms is varied …

Purpose To investigate, in a meta-analysis, the frequency of pulmonary embolism (PE) in
patients with COVID-19 and whether D-dimer assessment may be useful to select patients …

This document from the European Society of Thoracic Imaging (ESTI) and the European
Society of Radiology (ESR) discusses the role of imaging in the long-term follow-up of …

Purpose COVID-19 raises D-dimer (DD) levels even in the absence of pulmonary embolism
(PE), resulting in an increase in computed tomography pulmonary angiogram (CTPA) …

A high incidence of thrombosis in hospitalised patients with COVID-19 was identified early
during the pandemic. Accurately quantifying thrombotic risk may assist prognosis and guide …

Background Coronavirus disease 2019 (COVID-19) increases thrombosis in hospitalized
patients prompting adoption of different thromboprophylaxis strategies. Safety and efficacy of …

OBJECTIVES: Hypercoagulability may be a key mechanism for acute organ injury and death
in patients with severe coronavirus disease 2019, but the relationship between elevated …